CLINICAL_TRIALS
trial_result
· 2014-06-02
Clinical Trial Update: Phase 3/Safety & Efficacy of Esomeprazole in Infants [Phase 3]
Summary
Phase 3 trial results for esomeprazole in infants evaluating safety and efficacy for gastroesophageal reflux disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Gastroesophageal Reflux Disease (GERD) | Phase 3 | Status: COMPLETED | Results posted: 2014-06-02